The Food and Drug Administration on June 2 launched a new artificial intelligence (AI) tool.
FDA officials said Elsa, the tool, will help employees “work more efficiently.”
The agency is utilizing Elsa to speed up clinical protocol reviews and scientific evaluations, as well as to identify targets for inspections.
FDA officials described Elsa as a “large language model–powered AI tool designed to assist with reading, writing, and summarizing.” They said it can summarize adverse events to help with safety profile assessments, compare labels faster than humans, and generate code to help develop databases.
“Today marks the dawn of the AI era at the FDA with the release of Elsa, AI is no longer a distant promise but a dynamic force enhancing and optimizing the performance and potential of every employee,” FDA Chief AI Officer Jeremy Walsh said in a statement….